Antibody testing for the general population
This study tests a new platform to measure antibodies, which help your body fight off infections. It aims to understand how common the antibodies are in healthy adults and children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 65 years old, or your child is between 2 and 10 years old
- You (or your child) must sign a consent form
- You do not have a weakened immune system (like from an immune disorder or medications that suppress immunity)
- You do not have a long-term inflammatory condition (like an autoimmune disease, chronic stomach or bowel disease, or rheumatic disease)
- You have not taken any immune-modifying drugs in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is collecting blood samples from healthy donors to help researchers develop new antibodies for immune-based therapies (immunotherapy). It may lead to new treatments for various conditions.
This study takes small blood samples to learn how the immune system works in healthy people. It may help researchers better understand immune biology for future treatments, while you help by participating in regular research blood draws.
This study follows people who get a vaccine that is not mandatory to track how their antibody levels change over time. It helps understand how well the vaccine works in real life, which may inform future vaccination decisions.
This study looks for early signs of disease in healthy adults by checking blood and other samples. It may help find diseases sooner in the future.
This trial tests a blood test that looks for infection by analyzing tiny bits of DNA from microbes. It may help find infections faster in people with weakened immune systems, such as transplant recipients or those with blood cancers.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
Hear when a new Diagnostics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.